UAE’s coldest spot hits 3.5°C as mountain destination pauses operations for safety Dubai: Anyone planning a hike or winter outing at Jebel Jais this week will need to put plans on hold. The UAE’s ...

The Higher Education Commission (HEC) has announced LLM and PhD scholarships for talented students from Balochistan. Under the scheme, students from Balochistan will be awarded LLM scholarships at ...

Over 2,300 drones, including pyro and laser drones, will light up the sky Ras Al Khaimah is set to captivate the world once again with its most spectacular New Year’s Eve celebration to date, ...

ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

In many a school auditorium, a theater kid could be spotted sitting cross-legged with a peanut butter and jelly sandwich, surrounded by peers who had just belted their way through the entire Hamilton ...

BEIJING/HONG KONG, Sept 10 (Reuters) - U.S. investment firm Bain Capital has agreed to sell data centre operator WinTriX DC Group's China business to a consortium led by Guangdong Hec Technology ...

A former Newark police officer has filed a federal lawsuit alleging years of sexual harassment — including advances from Mayor Ras Baraka — and retaliation after testing positive for prescribed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

GLP-1 RAs are linked to an increased risk of NAION in type 2 diabetes patients, with semaglutide and liraglutide showing significant associations. The study involved over 3.8 million Medicare patients ...

Daraxonrasib gains FDA breakthrough therapy status for treating metastatic pancreatic cancer with KRAS G12X mutations, showing promising survival rates. The FDA has granted breakthrough therapy ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.